| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JACI.2010.02.020 |
| P698 | PubMed publication ID | 20451040 |
| P50 | author | Achim G Beule | Q47301304 |
| Peter W Hellings | Q55704857 | ||
| Philippe Gevaert | Q57339925 | ||
| Thibaut Van Zele | Q62081933 | ||
| P2093 | author name string | Claus Bachert | |
| Paul Van Cauwenberge | |||
| Gabriele Holtappels | |||
| Peter John Wormald | |||
| Wytske Fokkens | |||
| Susanne Mayr | |||
| Greet Hens | |||
| Fenna A Ebbens | |||
| P2860 | cites work | Oral steroids for nasal polyps | Q24246547 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxycycline | Q422442 |
| P304 | page(s) | 1069-1076.e4 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Oral steroids and doxycycline: two different approaches to treat nasal polyps | |
| P478 | volume | 125 |
| Q35824636 | A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS). |
| Q62937536 | A prospective investigation of predictive parameters for post-surgical recurrences in sinonasal polyposis |
| Q40903328 | A prospective randomized cohort study evaluating 3 weeks vs 6 weeks of oral antibiotic treatment in the setting of "maximal medical therapy" for chronic rhinosinusitis |
| Q40131613 | A survey on chronic rhinosinusitis: opinions from experts of 50 countries. |
| Q37832984 | Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management. |
| Q50123267 | Antihistamines for treating rhinosinusitis: systematic review and meta-analysis of randomised controlled studies |
| Q38021963 | Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations |
| Q35801948 | Assessing the safety and efficacy of drugs used in preparing the nose for diagnostic and therapeutic procedures: a systematic review |
| Q36204569 | Bacterial Pathogens and the Microbiome |
| Q92462881 | Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper |
| Q57787275 | Biomarkers in Chronic Rhinosinusitis with Nasal Polyps |
| Q38736622 | Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis |
| Q89491066 | Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis |
| Q54967891 | Chronic Rhinosinusitis-Related Smell Loss: Medical And Surgical Treatment Efficacy. |
| Q30416254 | Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly |
| Q36929874 | Chronic rhinosinusitis and emerging treatment options |
| Q26796528 | Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations |
| Q38139598 | Chronic rhinosinusitis: an update on current pharmacotherapy |
| Q38023962 | Chronic rhinosinusitis: from one disease to different phenotypes |
| Q38833522 | Chronic rhinosinusitis: the rationale for current treatments |
| Q30473876 | Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches |
| Q39170851 | Commonality of the IL-4/IL-13 pathway in atopic diseases |
| Q92579018 | Comparison of Corticosteroids by 3 Approaches to the Treatment of Chronic Rhinosinusitis With Nasal Polyps |
| Q26771861 | Comprehensive review on endonasal endoscopic sinus surgery |
| Q39148811 | Contemporary Use of Corticosteroids in Rhinology |
| Q51662443 | Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps. |
| Q89468973 | Current and Future Treatments of Rhinitis and Sinusitis |
| Q59795406 | Current understanding of allergic fungal rhinosinusitis |
| Q38763342 | Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter |
| Q52146781 | Doxycycline inhibits TGF-β1-induced extracellular matrix production in nasal polyp-derived fibroblasts. |
| Q95641851 | Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps |
| Q89564138 | Endotypes of Chronic Rhinosinusitis Across Ancestry and Geographic Regions |
| Q40625391 | Epithelium and stroma from nasal polyp mucosa exhibits inverse expression of TGF-β1 as compared with healthy nasal mucosa |
| Q38759891 | Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis |
| Q28069178 | Evidence and evidence gaps in therapies of nasal obstruction and rhinosinusitis |
| Q38227357 | Evidence and role of autoantibodies in chronic rhinosinusitis with nasal polyps. |
| Q36062767 | Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps |
| Q89367175 | Functional outcome after long-term low-dose trimethoprim/sulfamethoxazole in chronic rhinosinusitis with purulence: a prospective study |
| Q50238315 | Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery |
| Q34423484 | ICON: chronic rhinosinusitis |
| Q59356222 | Impact of antibiotics on smell dysfunction |
| Q47361796 | Increased serum amyloid A in nasal polyps is associated with systemic corticosteroid insensitivity in patients with chronic rhinosinusitis with nasal polyps: a pilot study. |
| Q37080838 | Infectious Chronic Rhinosinusitis |
| Q38738551 | International Consensus Statement on Allergy and Rhinology: Rhinosinusitis |
| Q35816380 | Involvement of Toll-like receptor 2 and epidermal growth factor receptor signaling in epithelial expression of airway remodeling factors |
| Q53158931 | Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps. |
| Q38370137 | Local immunoglobulin e in the nasal mucosa: clinical implications |
| Q97543018 | Low-dose macrolides for treating pediatric rhinosinusitis: A retrospective study and literature review |
| Q90522221 | Measuring antibiotic levels and their relationship with the microbiome in chronic rhinosinusitis |
| Q90111684 | Medical Management Strategies in Acute and Chronic Rhinosinusitis |
| Q93376637 | NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps |
| Q26866087 | Nasal polyposis: current trends |
| Q38268567 | Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis. |
| Q50487856 | Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis |
| Q38066109 | Oral steroid therapy in chronic rhinosinusitis with and without nasal polyposis. |
| Q24185937 | Oral steroids for nasal polyps |
| Q24235433 | Oral steroids for nasal polyps |
| Q90087724 | P-glycoprotein and chronic rhinosinusitis |
| Q42368875 | Paradigm shifts in the medical and surgical management of rhinologic and allergic disease |
| Q26771860 | Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options |
| Q53438428 | Post-operative steroid treatment for eosinophilic-type sinonasal polyposis. |
| Q47923013 | Potential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase-1 in Pathogenesis of Chronic Rhinosinusitis |
| Q28074654 | Recent advances in the surgical management of rhinosinusitis |
| Q38542580 | Remodeling and Repair in Rhinosinusitis |
| Q36100009 | Rhinosinusitis and aspirin-exacerbated respiratory disease. |
| Q26830200 | Role of innate immunity in the pathogenesis of chronic rhinosinusitis: progress and new avenues |
| Q37978476 | Role of medical therapy in the management of nasal polyps |
| Q34250503 | Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent |
| Q24185860 | Short-course oral steroids alone for chronic rhinosinusitis |
| Q24185867 | Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis |
| Q42277927 | Sinonasal manifestations in cystic fibrosis |
| Q38109671 | Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: systematic review and meta-analysis. |
| Q40623202 | Staphylococcus aureus and Chronic Airway Disease |
| Q36859706 | Steroid-independent upregulation of matrix metalloproteinase 9 in chronic rhinosinusitis patients with radiographic evidence of osteitis |
| Q34415626 | Structural organization and cellular localization of tuftelin-interacting protein 11 (TFIP11). |
| Q38891382 | Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. |
| Q38594062 | Surgical versus medical interventions in CRS and nasal polyps: comparative evidence between medical and surgical efficacy |
| Q24185864 | Systemic and topical antibiotics for chronic rhinosinusitis |
| Q43475763 | Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients |
| Q38608260 | Targeting key proximal drivers of type 2 inflammation in disease |
| Q57072687 | Tc17/IL-17A Up-Regulated the Expression of MMP-9 via NF-κB Pathway in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis |
| Q64106906 | The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis |
| Q42292834 | The impact of total immunoglobulin E levels on outcomes of maximal medical therapy for chronic rhinosinusitis |
| Q40051954 | The role of infection and antibiotics in chronic rhinosinusitis |
| Q90216711 | Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date |
| Q24185940 | Topical steroids for nasal polyps |
| Q24202139 | Topical steroids for nasal polyps |
| Q36571749 | Update on the management of chronic rhinosinusitis |
| Q36017642 | Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis. |
| Q52817429 | [Commentary on the guideline for rhinosinusitis - what is important, what is new?] |
| Q88690616 | [Complications and side effects of conservative treatment of rhinological diseases] |
Search more.